Viking Therapeutics, Inc. Common Stock (VKTX) Technical Analysis
$38.04▲2.84%
Market is closed - opens 7 PM, 29 Jun 2026
Insights
- Viking Therapeutics Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Viking Therapeutics Inc. stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Viking Therapeutics Inc. stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Viking Therapeutics Inc. stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 72.59 | Sell |
Stochastic | 88.53, 88.86 | Sell |
Ultimate Oscillator | 60.23 | Neutral |
Stochastic Relative Strength Index | 93.85, 96.61 | Sell |
Moving Average Convergence Divergence | 1.42, 0.34 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 32.88 | Buy |
20 | 31.22 | Sell |
50 | 31.6 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 34.01 | Buy |
20 | 32.43 | Buy |
50 | 31.83 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 34.16 | Buy |
20 | 32.27 | Buy |
50 | 31.98 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 36.56 | Buy |
20 | 33.93 | Buy |
50 | 31.83 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 38.1 | Buy |
20 | 35.69 | Buy |
50 | 32.13 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 41.29 |
Resistance L2 | 40.37 |
Resistance L1 | 38.68 |
Pivot Point | 37.76 |
Support L1 | 36.07 |
Support L2 | 35.15 |
Support L3 | 33.46 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.